Live Pfizer updates

Live Pfizer news coverage of developments with the latest updates. Stay on top of latest Pfizer news stories and find out what just happened, what is going on with Pfizer. The latest real-time news updates and headlines on Pfizer
Research Activity Up 15%, Bolstering National Rank
Blood Clot Cause in COVID Vaccinations Uncovered
Daily Multivitamins May Slow Biological Aging: Study
Pfizer's Antibody Shows Promise in Atopic Dermatitis Study
FDA Fully Approves Pfizer's BRAFTOVI for Metastatic CRC
TGA Product Information Safety Updates 25 February
When Does Cortisol Become Real Problem?
Microplastics Found in Prostate Tumors
Booster Jabs Reduce Risks Of Covid Deaths, Study Finds
Research: Booster Jabs Slash COVID-19 Death Risk
Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival In Metastatic Colorectal Cancer
TGA Product Information Safety Updates 17 February
Case Report Probes mRNA Vaccines-Cancer Link
Engineered Immune Cells Slash Brain Toxic Proteins
FDA Fast-Tracks HYMPAVZI for Hemophilia & B Treatment
Pfizer Unveils TrumpRx Program to Cut Drug Costs
TrumpRx.gov Launches to Lower Drug Prices
New Guidelines Standardize Post-Surgery Tumor Response
Pfizer's Monthly GLP-1 Shot Yields Strong Weight Loss
Medical AI Models Require Enhanced Context for Clinics
Alliance Foundation Phase III PATINA Study in NEJM
Nanoparticles Target Disease Proteins in Dementia, Cancer
€60m AI Drug Discovery Project Launched
Scholars Tackle Environmental, Energy Challenges
TGA Product Information Safety Updates 15 January
CtDNA Levels Post-Therapy Outshine PCR in Cancer Recurrence
Healthcare Innovator Joins Health Data Research Team
Pfizer's BRAFTOVI Boosts Response in Metastatic CRC
Expert Predicts 2026 Viral Threats
Trachoma Intervention Needs Drop Below 100 Million
Pfizer Stands by 2025 EPS, Unveils 2026 Guidance
Pfizer Announces Q1 2026 Dividend
Research: Cannabis Use Doesn't Hinder Quitting Nicotine Vaping
Researchers Selected To National Academy Of Inventors
AI Model Boosts Early Breast Cancer Risk Assessment
Giredestrant Boosts Survival in Early Breast Cancer Trial
Sacituzumab Govitecan Matches Standard Care in Breast Cancer
Tucatinib Boosts First-Line Therapy in HER2+ Breast Cancer
Pfizer, YaoPharma Ink Exclusive Collaboration Pact
HYMPAVZI Cuts Bleeds 93% in Hemophilia A/B With Inhibitors
Endurance Athletes Face 4x Higher Irregular Heartbeat Risk
Multivitamin Impact Tied to Diet, Blood Pressure
COVID Risk Lowest Since 2020, Boosters Still Urged
Pfizer Finalizes Metsera Acquisition
T-Cell Patterns in Colorectal Cancer Progression Found
Pfizer Gets Early FTC Nod for Metsera Buy
Pfizer Sues Metsera, Directors, Novo Nordisk Over Merger
PCSK9 Inhibitor Cuts First Heart Attack, Stroke Risk